Mr. Umesh V. Parikh, the Designated Person and Chief Financial Officer of Zydus Wellness Limited, executed an open market acquisition of 250 equity shares of the company. The transaction, which took place on March 2, 2026, resulted in his total shareholding increasing to 19,005 shares (0.00%). This disclosure was formally submitted to the stock exchanges on March 3, 2026, fulfilling the requirements for continual disclosure by an insider.
Insider Share Acquisition Disclosure
Zydus Wellness Limited has informed the stock exchanges regarding a transaction involving one of its key managerial personnel. The disclosure pertains to the acquisition of equity shares by Mr. Umesh V. Parikh, who serves as the Designated Person and the Chief Financial Officer (CFO) of the company.
Details of the Transaction
The acquisition involved 250 equity shares of the company, each with a face value of ₹2/-. The total value paid for this purchase amounted to Rs. 95,019.00. The transaction was executed on the open market on March 2, 2026.
Change in Shareholding Pattern
Prior to this acquisition, Mr. Parikh held 18,755 Equity Shares (0.00%). Following the purchase of the additional 250 shares, his total holding in Zydus Wellness Limited now stands at 19,005 Equity Shares, maintaining a total shareholding percentage of 0.00%.
Compliance and Intimation
The details were presented in the prescribed Form “B” as required under the SEBI Insider Trading Regulations. The date of acquisition was March 2, 2026, while the formal date of intimation to the company and the exchanges was March 3, 2026. The filing was authorized by Mr. Nandish P. Joshi, Company Secretary & Compliance Officer.
Derivative Trading Status
The filing confirmed that there were no transactions involving trading in derivatives (such as futures or options) by Mr. Parikh during the relevant period.
Source: BSE
